We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OIG: FDA Increasing Generic Preapproval Inspections, but Falling Short on Foreign Front
OIG: FDA Increasing Generic Preapproval Inspections, but Falling Short on Foreign Front
The FDA increased its preapproval inspections of generics makers by 60 percent between fiscal years 2011 and 2013, but failed to conduct all of those requested by agency reviewers, a new report finds.